Bio Green Med Solution, Inc. (BGMS) Return on equity 2016–2025
Bio Green Med Solution, Inc. (BGMS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-43.8%FY2025 · since FY2016: -82.6% → -43.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -43.8% | — |
| FY2023 | -3715.8% | -3582.8 pp |
| FY2022 | -133.0% | -84.0 pp |
| FY2021 | -49.0% | -23.6 pp |
| FY2020 | -25.4% | — |
| FY2018 | -47.7% | -13.4 pp |
| FY2017 | -34.3% | +48.3 pp |
| FY2016 | -82.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BGMS financial trends
BGMS RevenueBGMS Net incomeBGMS Net marginBGMS Gross profitBGMS Gross marginBGMS Operating incomeBGMS Operating marginBGMS Operating cash flowBGMS Free cash flowBGMS Capital expendituresBGMS Stock buybacksBGMS Dividends paidBGMS Total assetsBGMS Total liabilitiesBGMS Shareholders’ equityBGMS overview →